Gefitinib inhibits M2-like polarization of tumor-associated macrophages in Lewis lung cancer by targeting the STAT6 signaling pathway.
about
Gefitinib inhibits M2-like polarization of tumor-associated macrophages in Lewis lung cancer by targeting the STAT6 signaling pathway.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Gefitinib inhibits M2-like pol ...... g the STAT6 signaling pathway.
@en
Gefitinib inhibits M2-like pol ...... g the STAT6 signaling pathway.
@nl
type
label
Gefitinib inhibits M2-like pol ...... g the STAT6 signaling pathway.
@en
Gefitinib inhibits M2-like pol ...... g the STAT6 signaling pathway.
@nl
prefLabel
Gefitinib inhibits M2-like pol ...... g the STAT6 signaling pathway.
@en
Gefitinib inhibits M2-like pol ...... g the STAT6 signaling pathway.
@nl
P2093
P2860
P356
P1476
Gefitinib inhibits M2-like pol ...... g the STAT6 signaling pathway.
@en
P2093
Gui-Kai Liang
Jie-Qiong Zhang
Muhammad Tariq
Qiao-Jun He
P2860
P2888
P304
P356
10.1038/APS.2017.124
P577
2017-10-12T00:00:00Z
P6179
1092186247